seeing the news about the nevaada festival was a real wake up call. it kinda proves what i’ve been thinking about, that the context matters way more than the name. tbh, the fact that the board couldn’t even test the samples to know if it was contamination or a direct reaction to the peptide is the part that sticks with me. it just highlights that without clear parameters - like knowing the source was pure, or if the storage was compromised - it’s impossible to draw any straight line from hype to actual science. im’m worried about the variability of protocols when people are just showing off stuff, not running controlled trials. is there a consensus in the literature about what the biggest risk factor is when using these compounds outside of a tightly controlled research setting?